Advertisement

Topics

Regeneron quarterly profit nearly doubles

02:41 EDT 3 Aug 2017 | Reuters

(Reuters) - Regeneron Pharmaceuticals Inc reported a nearly 98 percent rise in quarterly profit on Thursday, partly helped by higher demand for its flagship eye treatment, Eylea.

Original Article: Regeneron quarterly profit nearly doubles

NEXT ARTICLE

More From BioPortfolio on "Regeneron quarterly profit nearly doubles"

Quick Search
Advertisement